ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly interest income ($M) [reported separately through Q3 2025] ($M)
Annual figures from Eli Lilly's filings and investor materials
Latest, FY2024
175
Period ended Dec 31, 2024
Change on a year earlier
+0.9%
174 in FY2023
History
17 years
Since FY2008
Sources
13
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Interest income ($M) [reported separately through Q3 2025] ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2024 | Dec 31, 2024 | 175 | +0.9% | Form 10-K (filed 2025-02-19) ↗ |
| FY2023 | Dec 31, 2023 | 174 | +176.4% | Form 10-K (filed 2024-02-21) ↗ |
| FY2022 | Dec 31, 2022 | 62.8 | +147.2% | Form 10-K (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 25.4 | -23.0% | Form 10-K (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 33 | -59.0% | Form 10-K (filed 2021-02-17) ↗ |
| FY2019 | Dec 31, 2019 | 80.4 | -49.5% | Form 10-K (filed 2020-02-19) ↗ |
| FY2018 | Dec 31, 2018 | 159 | -4.3% | Form 10-K (filed 2020-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 166 | +53.1% | Form 10-K (filed 2020-02-19) ↗ |
| FY2016 | Dec 31, 2016 | 109 | +24.9% | Form 10-K (filed 2017-02-21) ↗ |
| FY2015 | Dec 31, 2015 | 87 | -28.1% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 121 | +1.1% | Form 10-K (filed 2015-02-19) ↗ |
| FY2013 | Dec 31, 2013 | 120 | +14.0% | Form 10-K (filed 2014-02-19) ↗ |
| FY2012 | Dec 31, 2012 | 105 | +31.4% | Form 10-K (filed 2013-02-21) ↗ |
| FY2011 | Dec 31, 2011 | 79.9 | +53.9% | Form 10-K (filed 2012-02-24) ↗ |
| FY2010 | Dec 31, 2010 | 51.9 | -31.0% | Form 10-K (filed 2012-02-24) ↗ |
| FY2009 | Dec 31, 2009 | 75.2 | -135.7% | Form 10-K (filed 2012-02-24) ↗ |
| FY2008 | Dec 31, 2008 | -211 | – | Form 10-K (filed 2011-02-22) ↗ |
Cite this data
StockData. (2026). Eli Lilly Interest income ($M) [reported separately through Q3 2025] ($M), annual FY2008–FY2024 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_int_inc
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.